by TractManager | Mar 23, 2017 | Clinical Utility Evaluation
This report evaluates the clinical utility for MTHFR pharmacogenomic genotyping in pediatric or adult patients to alter drug choice, drug dose, or otherwise mitigate drug treatment according to patient genotype in order to avoid adverse events, maintain adherence, and...
by TractManager | Mar 23, 2017 | Health Technology Assessment
Purpose of Technology: Capsule endoscopy (CE), also called wireless capsule endoscopy or video capsule endoscopy, is a minimally invasive procedure in which the patient swallows a multivitamin-sized capsule containing a miniaturized video camera, light transmitter,...
by TractManager | Mar 21, 2017 | Emerging Technology Report
Binimetinib is an investigational, oral small-molecule targeting the mitogen-activated protein kinase (MAPK) pathway. Mitogen-activated protein kinase enzyme (MEK) is a key protein kinase in the MAPK pathway, which regulates several key cellular activities, including...
by TractManager | Mar 16, 2017 | Emerging Technology Report
Kisqali is an oral cyclin-dependent kinases 4 and 6 (CDK 4/6) inhibitor. CDK 4/6 are commonly overexpressed in breast cancer tumors, and increased CDK 4/6 activity is associated with resistance to hormone therapy. Kisqali is intended for use in combination with...
by TractManager | Mar 16, 2017 | Health Technology Assessment
Purpose of Technology: Occupational therapy (OT) for attention-deficit/hyperactivity disorder (ADHD) encompasses a wide array of interventions, with the aim of increasing function in all aspects of life and settings (school, home, etc.). Specific interventions vary...
Recent Comments